Search results
VCU to offer bachelor’s degree in pharmaceutical sciences in effort to address medication shortages
WRIC 8 News Richmond· 14 hours agoVirginia Commonwealth University (VCU) will begin offering a bachelor’s degree in pharmaceutical...
Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023)
Simply Wall St. via Yahoo Finance· 6 days agoThe company's shares are up 13% from a week ago. Risk Analysis Before you take the next step you...
India can be a real alternative to China in pharmaceuticals
Nikkei Asian Review· 19 hours agoGopal Nadadur is based in New Delhi as vice president for South Asia at The Asia Group, a strategic...
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoPhathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript May 11, 2024 Phathom ...
Merrimack Pharmaceuticals (NASDAQ:MACK) Lowered to Sell at StockNews.com
ETF DAILY NEWS· 19 hours agoStockNews.com lowered shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Free Report) from a hold rating to a sell rating in a research note issued to investors on Monday.
ANI Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 4 days agoEarnings per share (EPS) also surpassed analyst estimates significantly. Looking ahead, revenue is...
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript May 11, 2024 NovaBay ...
Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
Simply Wall St. via Yahoo Finance· 5 days agoThe company's share price is broadly unchanged from a week ago. Risk Analysis Before we wrap up,...
Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023)
Simply Wall St. via Yahoo Finance· 5 days agoThe company's share price is broadly unchanged from a week ago. Balance Sheet Analysis Just as...
Capital One Financial Analysts Decrease Earnings Estimates for Olema Pharmaceuticals, Inc....
ETF DAILY NEWS· 21 hours agoOlema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Equities research analysts at Capital One Financial cut their FY2028 earnings per share estimates for shares of Olema ...